Drugs / Tacrine
last change Nov 2013 re-read 3 minutes ago

Tacrine

Small molecule

Developed for
cocaine dependence
Investigated by
Midwest Biomedical Research Foundation

Regulatory milestones approvals, filings & regulatory actions · 2 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Label expansion US (FDA) COGNEX — 1997-10-10 fda.gov ↗
Approved US (FDA) COGNEX — 1993-09-09 fda.gov ↗

Trials 1

today
US approved 1993
NCT01406522 · Ph 2
19931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01406522 Oct 2012 → Sep 2013 cocaine dependence Midwest Biomedical Research Foundation Withdrawn No outcome recorded

Evidence & citations 12 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Tacrine ClinicalTrials.gov intervention name — accepted as the source's own label NCT01406522 ↗
Known as Alzyme ChEMBL registry synonym — accepted as the source's own label CHEMBL95 ↗
Known as CI-970 ChEMBL registry synonym — accepted as the source's own label CHEMBL95 ↗
Known as Cognex ChEMBL registry synonym — accepted as the source's own label CHEMBL95 ↗
Known as NSC-72108 ChEMBL registry synonym — accepted as the source's own label CHEMBL95 ↗
Known as Tacrina ChEMBL registry synonym — accepted as the source's own label CHEMBL95 ↗
Known as Tacrinal ChEMBL registry synonym — accepted as the source's own label CHEMBL95 ↗
Known as Tacrine hcl ChEMBL registry synonym — accepted as the source's own label CHEMBL95 ↗
Known as TACRINE HYDROCHLORIDE ChEMBL registry synonym — accepted as the source's own label CHEMBL95 ↗
Action Inhibit “Tacrine is a centrally acting, reversible inhibitor of AChE and BuChE” NCT01406522 ↗
Modality Small molecule — CHEMBL95 ↗
Route Oral “potential for oral tacrine” NCT01406522 ↗